Same Indication

Lorazepam vs Pembrolizumab

Lorazepam vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Lorazepam and Pembrolizumab.

Mechanism of Action

Lorazepam: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Lorazepam — 10-20 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Lorazepam — C15H10Cl2N2O2.

Molecular Weight: Lorazepam — 321.1580 g/mol.

Type: Lorazepam — Small molecule; Pembrolizumab — Antibody.